Pharmacyclics LLC - Company Profile
Powered by 
All the sales intelligence you need on Pharmacyclics LLC in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Pharmacyclics LLC fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Pharmacyclics LLC.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Pharmacyclics LLC (Pharmacyclics), a subsidiary of Abbvie, discovers and develops small-molecule drugs for treating cancer and immune related diseases. It harnesses its core expertise in the development of cancer treatment and chemistry to develop proprietary cancer drug candidates. Strategic partnerships and synergy with parent company are its strengths, even as product side effects could be a cause for concern. However, growing chronic lymphocytic leukemia market, growing market for cancer treatments, and changing demographics could provide ample opportunities for the company. Competitive environment, government regulations, and dependence on third parties could affect the business prospects of the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer